Overview

Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases

Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the clinical efficacy and safety of continuous Endostar infusion combined with radiotherapy for treatment of brain metastases.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Collaborator:
The First People's Hospital of Lianyungang
Treatments:
Endostar protein